Search
for
Sort by
Research 91–120 of 283
- Analysis of benign prostatic obstruction surgery: A long-term evaluation in a real-life context
- Topical Application of Thermobalancing Therapy Enabled by Therapeutic Device Treats Enlarged Prostate and Improves Men's Quality of Life; New Opportunity in BPH Treatment
- Review: Dutasteride, fesoterodine, and finasteride are beneficial for lower urinary tract symptoms in older patients
- BPH: costs and treatment outcomes.
- Ezetimibe Reduces Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia
- Major role for 5-alpha reductase inhibitors in the aging male
- Photosensitive Trichothiodystrophy with Complex Cerebral Abnormalities
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Doxazosin and finasteride alone or in combination: the PREDICT study
- 5α-Reductase inhibitor therapy: Should physicians be concerned with persistent diminished libido, erectile dysfunction and depression in a subset of patients?
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Steroid 5α-reductase inhibition by polymethoxyflavones
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- Endocrine control of benign prostatic hyperplasia
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- 5α-Reductase Inhibitors (5ARIs) and Male Reproduction
- Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy
- Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- Effects of 5-alpha reductase inhibitors
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies